Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of childbirth by midwives: clinical evidence and guidelines
2013	HAYES, Inc.	Radiesse voice injectable implant (Merz Aesthetics Inc.) for treatment of glottic insufficiency including vocal cord paralysis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Frequency of blood pressure measurements for children and adults: evidence-based guidelines
2013	National Institute for Health and Care Excellence (NICE)	Eltrombopag for treating chronic immune thrombocytopenia. NICE technology appraisal guidance 293
2013	Agency for Healthcare Research and Quality (AHRQ)	Local nonsurgical therapies for stage 1 and symptomatic obstructive non–small-cell lung cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	External devices for cervical spine immobilization in the pre-hospital setting: clinical effectiveness
2013	HAYES, Inc.	Remicade (infliximab; Janssen Biotech Inc.) for first-line treatment of pediatric crohn's disease
2013	Blue Cross Blue Shield Association (BCBS)	Percutaneous left atrial appendage closure therapy for the prevention of stroke
2013	National Institute for Health and Care Excellence (NICE)	Aflibercept solution for injection for treating wet age-related macular degeneration. NICE technology appraisal guidance 294
2013	Agency for Healthcare Research and Quality (AHRQ)	Migraine in children: preventive pharmacologic treatments
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Removal of intravenous lines following outpatient day procedures: guidelines
2013	HAYES, Inc.	Robotically assisted mitral valve repair using the da Vinci surgical system (Intuitive Surgical Inc.)
2013	National Institute for Health and Care Excellence (NICE)	Ocriplasmin for treating vitreomacular traction. NICE technology appraisal guidance 297
2013	Agency for Healthcare Research and Quality (AHRQ)	Migraine in adults: preventive pharmacologic treatments
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ferumoxytol versus other intravenous iron therapies for anemia: a review of the clinical and cost-effectiveness and guidelines
2013	HAYES, Inc.	S-ICD (Subcutaneous Implantable Cardioverter Defibrillator; Boston Scientific Corp.) for prevention of sudden cardiac death
2013	Blue Cross Blue Shield Association (BCBS)	Noninvasive prenatal cell-free fetal DNA-based screening for aneuploidies other than trisomy 21
2013	National Institute for Health and Care Excellence (NICE)	Ranibizumab for treating choroidal neovascularisation associated with pathological myopia. NICE technology appraisal guidance 298
2013	Agency for Healthcare Research and Quality (AHRQ)	Oral contraceptive use for the primary prevention of ovarian cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous ketamine for the treatment of pain syndromes: clinical effectiveness
2013	HAYES, Inc.	Single-Incision Laparoscopic Surgery (SILS) for hysterectomy for benign disease
2013	National Institute for Health and Care Excellence (NICE)	Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people. NICE technology appraisal guidance 300
2013	Agency for Healthcare Research and Quality (AHRQ)	Bariatric surgery and nonsurgical therapy in adults with metabolic conditions and a body mass index of 30.0 to 34.9 kg/m2
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nabilone for chronic pain: clinical effectiveness, safety, and guidelines
2013	HAYES, Inc.	Solesta (Q-Med AB) for treatment of fecal incontinence
2013	National Institute for Health and Care Excellence (NICE)	Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy. NICE technology appraisal guidance 301
2013	Agency for Healthcare Research and Quality (AHRQ)	Pharmacologic and mechanical prophylaxis of venous thromboembolism among special populations
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nabilone for nausea or vomiting not related to chemotherapy: clinical effectiveness and safety
2013	HAYES, Inc.	Stelara (ustekinumab; Janssen Biotech Inc.) for treatment of psoriatic arthritis
2013	National Institute for Health and Care Excellence (NICE)	Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal). NICE technology appraisal guidance 302
2013	Agency for Healthcare Research and Quality (AHRQ)	Treatment strategies for patients with peripheral artery disease
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Portable bone mineral density scanners for screening and diagnosis of osteoporosis: uses, limitations, and guidelines
2013	HAYES, Inc.	Transarterial embolization with embozene microspheres (CeloNova BioSciences Inc.) for treatment of hepatocellular carcinoma and other liver tumors
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of medullary neurostimulators for the treatment of chronic non-cancer pain]
2013	Scottish Health Technologies Group (SHTG)	Does the addition of positron emission tomography/computed tomography (PET/CT) to the routine investigation and assessment of patients with melanoma yield clinical and economic benefits?
2013	Agency for Healthcare Research and Quality (AHRQ)	Local therapies for unresectable primary hepatocellular carcinoma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The prevention of blood-borne infection transmission during immunization: clinical evidence and guidelines
2013	HAYES, Inc.	Triangle tilt surgery for treatment of obstetric brachial plexus injury
2013	Scottish Health Technologies Group (SHTG)	Open, laparoscopic and robot-assisted laparoscopic radical prostatectomy for localised prostate cancer.
2013	Agency for Healthcare Research and Quality (AHRQ)	Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: a comparative effectiveness review
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The use of spine boards in the pre-hospital setting for the stabilization of patients following trauma: a review of the clinical evidence and guidelines
2013	HAYES, Inc.	VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2013	Agency for Healthcare Research and Quality (AHRQ)	Interventions to modify health care provider adherence to asthma guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The emotional freedom technique for the treatment of post-traumatic stress disorder, depression, or anxiety: clinical evidence
2013	HAYES, Inc.	Vision therapy for convergence insufficiency and accommodative dysfunction in children
2013	Agency for Healthcare Research and Quality (AHRQ)	Pressure ulcer treatment strategies: comparative effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pentazocine versus short-acting opioids for chronic or acute pain: a review of the clinical effectiveness
2013	HAYES, Inc.	Xofigo (radium-223 dichloride; Bayer HealthCare Pharmaceuticals Inc.) for treatment of bone metastases in castration-resistant prostate cancer
2013	Agency for Healthcare Research and Quality (AHRQ)	Pressure ulcer risk assessment and prevention: comparative effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Protease inhibitor use for chronic hepatitis C infection in prior null responders and recurrent hepatitis C infection post liver transplant: a review of the clinical evidence
2013	Agency for Healthcare Research and Quality (AHRQ)	Otitis media with effusion: comparative effectiveness of treatments
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Timing of enoxaparin administration for the prophylaxis of venous thromboembolism: clinical evidence and guidelines
2013	NIHR Health Technology Assessment programme	Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study
2013	Agency for Healthcare Research and Quality (AHRQ)	Interventions to improve cardiovascular risk factors in people with serious mental illness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Single-bed versus multi-bed rooms for the prevention of hospital acquired infections: clinical effectiveness and guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Child exposure to trauma: comparative effectiveness of interventions addressing maltreatment
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Precautionary period for the safe handling of excreta or body fluids in patients receiving cytotoxic or antineoplastic therapy: clinical evidence and guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Interventions for the prevention of Posttraumatic Stress Disorder (PTSD) in adults after exposure to psychological trauma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism: a review of the clinical and cost-effectiveness
2013	Agency for Healthcare Research and Quality (AHRQ)	PCA3 testing for the diagnosis and management of prostate cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retesting patients with sleep apnea: guidelines and recommendations
2013	NIHR Health Technology Assessment programme	Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis
2013	Agency for Healthcare Research and Quality (AHRQ)	Allergen-specific immunotherapy for the treatment of allergic rhinoconjunctivitis and/or asthma: comparative effectiveness review
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hydroxyethyl starch versus other plasma volume expanders: a review of the clinical and cost-effectiveness, and guidelines for use
2013	Agency for Healthcare Research and Quality (AHRQ)	Strategies to prevent weight gain among adults
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Forced air warming units for adults undergoing surgery: clinical evidence
2013	Agency for Healthcare Research and Quality (AHRQ)	Primary care management of abnormal uterine bleeding
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low molecular weight heparins versus new oral anticoagulants for long-term thrombosis prophylaxis and long-term treatment of DVT and PE: a review of the clinical and cost-effectiveness
2013	Scottish Health Technologies Group (SHTG)	Are silver dressings clinically effective and cost effective for the healing of infected wounds and the prevention of wound infection relative to other types of dressing?
2013	Agency for Healthcare Research and Quality (AHRQ)	Interventions for feeding and nutrition in cerebral palsy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-acting beta-agonists and inhaled corticosteroids for treatment of chronic obstructive pulmonary disease: a review of the clinical efficacy and cost-effectiveness
2013	National Institute for Health and Care Excellence (NICE)	Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events. NICE interventional procedures guidance 472
2013	The Netherlands Organisation for Health Research and Development (ZonMw)	[Accuracy and cost-effectiveness of two clinical decision rules for the diagnosis of deep vein thrombosis and pulmonary embolism in residents of nursing homes and homes for the elderly]
2013	Scottish Health Technologies Group (SHTG)	Does the addition of positron emission tomography/computed tomography (PET/CT) to the routine investigation and assessment of patients with sarcoidosis yield clinical and economic benefits?
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: mammography in two directions as standard
2013	National Institute for Health and Care Excellence (NICE)	Uterine artery embolisation for treating adenomyosis. NICE interventional procedures guidance 473
2013	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of dynamic elastomeric fabric orthoses (DEFOs) for cerebral palsy?
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sleep medications for adults diagnosed with insomnia: clinical evidence and harms
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: calcium score and the risk of cardiovascular disease
2013	National Institute for Health and Care Excellence (NICE)	Negative pressure wound therapy for the open abdomen. NICE interventional procedures guidance 467
2013	Scottish Health Technologies Group (SHTG)	Can wrist splints or steroid injections reduce the need for decompression surgery in carpal tunnel syndrome?
2013	Andalusian Health Technology Assessment Area (AETSA)	[Biological therapies in the treatment of ankylosing spondylitis: a comparison of efficacy and safety between different biological inhibitors of tumour necrosis factor-alpha]
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: national population screening programme for bowel cancer
2013	National Institute for Health and Care Excellence (NICE)	Phrenic nerve transfer in brachial plexus injury. NICE interventional procedures guidance 468
2013	Scottish Health Technologies Group (SHTG)	What is the sensitivity and specificity of PET/CT compared with other diagnostic imaging modalities in determining the cause of pyrexia of unknown origin (PUO)? What is the clinical and cost effectiveness of PET/CT as a first-line investigation in patients with PUO?
2013	Andalusian Health Technology Assessment Area (AETSA)	[Monoclonal antibodies associated with chemotherapy as first line therapy in metastatic colorectal cancer: relative efficacy, safety and efficiency]
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: Continuing a population screening trial
2013	National Institute for Health and Care Excellence (NICE)	Implantation of a duodenal–jejunal bypass sleeve for managing obesity. NICE interventional procedures guidance 471
2013	Health Council of the Netherlands Gezondheidsraad (GR)	The individual, collective and public importance of vaccination
2013	National Institute for Health and Care Excellence (NICE)	Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia. NICE interventional procedures guidance 466
2013	Scottish Health Technologies Group (SHTG)	What is the clinical effectiveness, cost effectiveness and implications for safety of assessing anti-tumour necrosis factor (TNF)α drug levels and antibodies in children with moderate to severe inflammatory bowel disease compared with existing clinical strategies in use in NHS Scotland?
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and cost-effectiveness of molecular techniques in the intraoperative assessment of the sentinel lymph node]
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Vaccination of infants against pneumococcal infections (3)
2013	National Institute for Health and Care Excellence (NICE)	Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease. NICE interventional procedures guidance 461
2013	Scottish Health Technologies Group (SHTG)	PET/CT for the inversitgation of paraneoplastic syndromes (PNS)
2013	Andalusian Health Technology Assessment Area (AETSA)	[New treatments in organ-confined cancer vs. prostatectomy. Systematic review. Ablation with cryotherapy, HIFU and laser-therapy]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Summary of the exploration of the scientific literature on the effects of prostate cancer screening decision aids for the expert panel of the Collège des médecins du Québec]
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: bowel cancer screening by pill camera
2013	National Institute for Health and Care Excellence (NICE)	Translaryngeal tracheostomy. NICE interventional procedures guidance 462